Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enovix Corporation filings document the regulatory disclosures of an advanced lithium-ion battery manufacturer commercializing silicon-anode battery architectures. Recent Form 8-K reports cover operating results, Regulation FD updates, customer qualification and commercial updates, executive changes, manufacturing-scale communications and board-authorized capital actions.
The filing record also includes capital-structure disclosures related to convertible senior notes, warrants to purchase common stock, share repurchase plans and common-stock matters. Proxy materials document board elections, executive compensation, equity awards and shareholder voting items, while current reports provide formal exhibits for press releases and material agreements.
Enovix Corp’s Chief Accounting Officer, Kristina Truong, reported a routine tax-related share withholding on a Form 4. On January 10, 2026, 282 shares of Enovix common stock were withheld at $7.92 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs).
After this transaction, Truong beneficially owned 194,023 shares, which includes 144,031 shares issuable upon future vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs). According to the disclosure, 50% of these PRSUs are scheduled to be released on March 2, 2026, with the remaining 50% scheduled for release on March 1, 2027, with each PRSU convertible into one share upon settlement.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported routine share withholding transactions related to vesting stock awards. On January 8, 2026, a total of 4,361 shares of Enovix common stock were withheld at $7.91 per share to cover tax obligations from the vesting of restricted stock units. After these transactions, Chakravarthy beneficially owned 410,459 shares of common stock directly.
The filing notes that this total includes 289,249 shares issuable upon future vesting and settlement of RSUs and 20,786 vested performance RSUs, with half of those PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027. A separate ownership line reflects 282,906 RSU-based shares plus the same 20,786 vested PRSUs, underscoring that a significant portion of the position is tied to ongoing equity awards rather than currently settled shares.
Enovix Corp Chief Accounting Officer Kristina Truong reported a routine tax-related share withholding. On January 8, 2026, 1,746 shares of common stock were withheld at $7.91 per share to cover taxes due on vested restricted stock units (RSUs).
After this transaction, Truong beneficially owns 194,305 shares of Enovix common stock. This figure includes 144,507 shares issuable upon vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs), with half of the PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported routine share withholding tied to equity compensation. On January 8, 2026, 1,493 and 4,544 shares of common stock were withheld at $7.91 per share to cover tax obligations arising from vesting restricted stock units (RSUs).
After these transactions, Marathe directly holds 927,421 shares of Enovix common stock. This figure includes 635,639 shares issuable upon future RSU vesting and 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. These movements reflect administrative tax withholding rather than discretionary open‑market trades.
Enovix Corporation reported that President and CEO Rajendra K. Talluri had shares of common stock withheld to cover taxes on vesting restricted stock units. On January 8, 2026, 4,301 and 13,725 shares of Enovix common stock were withheld at a price of $7.91 per share, with both transactions coded "F" and described as satisfying tax withholding obligations in connection with RSU vesting.
After these transactions, Talluri beneficially owned 2,243,254 shares of Enovix common stock directly, which includes 1,569,522 shares issuable upon settlement of RSUs and 95,551 vested performance RSUsMarch 2, 2026 and March 1, 2027, reflecting ongoing equity-based compensation rather than an open-market sale.
Enovix Corp’s Chief Operating Officer Ajay Marathe reported a tax-related share withholding tied to restricted stock units. On January 6, 2026, 42,557 shares of Enovix common stock were withheld at a price of $8.68 per share to satisfy tax obligations arising from the vesting of RSUs. After this withholding, Marathe beneficially owned 933,458 shares, including 638,458 shares issuable upon future RSU vesting and settlement and 33,170 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027, each representing the right to receive one share of Enovix common stock upon settlement.
Enovix Corp’s Chief Accounting Officer, Kristina Truong, reported a routine tax-related share withholding. On January 5, 2026, 697 shares of Enovix common stock were withheld at $8.73 per share to satisfy tax obligations tied to the vesting of restricted stock units (RSUs).
After this transaction, Truong beneficially owns 196,051 shares of Enovix common stock. This amount includes 147,679 shares issuable upon future RSU vesting and 4,978 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each performance RSU converts into one share upon settlement.
Enovix Corp's Chief Legal Officer, Arthi Chakravarthy, reported an automatic share withholding tied to equity compensation. On December 24, 2025, 2,217 shares of Enovix common stock were withheld at $8.27 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs). After this transaction, Chakravarthy beneficially owned 418,228 shares, including 297,316 shares issuable upon future RSU vesting and 20,786 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half scheduled for release on March 1, 2027, each representing the right to receive one share of Enovix common stock.
Enovix Corp officer Kristina Truong, the Chief Accounting Officer, reported a routine equity transaction on December 13, 2025 related to restricted stock vesting.
The filing shows 1,013 shares of common stock were withheld at $ 8.64 per share to satisfy tax withholding obligations when her restricted stock units vested. After this, she beneficially owned 199,044 shares of Enovix common stock.
This total includes 153,082 shares that may be issued upon the vesting and settlement of RSUs and 4,978 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each performance RSU represents a contingent right to receive one share of common stock upon settlement.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported a stock transaction dated December 14, 2025. The filing shows that 7,338 shares of common stock were withheld at $8.64 per share to cover tax withholding obligations triggered by the vesting of restricted stock units on that date.
After this transaction, Marathe is reported to beneficially own 980,535 shares of Enovix common stock. This total includes 727,116 shares issuable upon the vesting and settlement of RSUs and 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the other half on March 1, 2027, each PRSU representing the right to receive one share upon settlement.